Target Name: MYO1A
NCBI ID: G4640
Review Report on MYO1A Target / Biomarker Content of Review Report on MYO1A Target / Biomarker
MYO1A
Other Name(s): MYHL | OTTHUMP00000195072 | MIHC | myosin, heavy polypeptide-like (100kD) | myosin, heavy polypeptide-like 110kDa | BBM-I | brush border myosin I | Brush border myosin-I | MYO1A variant 2 | Myosin-Ia | Brush border myosin I | Myosin IA, transcript variant 2 | Myosin, heavy polypeptide-like (100kD) | Myosin I heavy chain | DFNA48 | Unconventional myosin-Ia | MYO1A_HUMAN | myosin IA | BBMI | myosin I heavy chain | Myosin IA

MYH Gene Linked To Muscle Growth and Development

Myostatin, also known as myostatin gene 1A (MYH), is a protein that is expressed in muscle tissue and is responsible for regulating muscle growth and development. Mutations in the MYH gene have been linked to a variety of muscle-related conditions, including muscle dystrophy and myopathies. Despite the significant impact of MYH on muscle biology, the precise mechanism of its action is not well understood.

One potential mechanism by which MYH may regulate muscle growth and development is through the inhibition of the myostatin-protein complex. Myostatin is a 25 kDa protein that is expressed in muscle tissue and plays a critical role in regulating muscle growth and development. The myostatin-protein complex is a protein complex that includes the myostatin protein and several other proteins that are involved in regulating muscle growth and development.

Several studies have suggested that mutations in the MYH gene may result in the formation of an unstable myostatin-protein complex that is less effective at inhibiting muscle growth and development. This may lead to an increase in muscle mass and a corresponding improvement in athletic performance.

Another potential mechanism by which MYH may regulate muscle growth and development is through the regulation of muscle cell apoptosis. Myostatin has been shown to play a role in the regulation of apoptosis, which is the process by which cells undergo programmed cell death.

Several studies have suggested that mutations in the MYH gene may result in the inhibition of myostatin's ability to induce apoptosis in muscle cells. This may lead to an increase in muscle cell apoptosis and a corresponding improvement in muscle mass and athletic performance.

In conclusion, MYH is a protein that is expressed in muscle tissue and is responsible for regulating muscle growth and development. Mutations in the MYH gene have been linked to a variety of muscle-related conditions, including muscle dystrophy and myopathies. Further research is needed to fully understand the precise mechanism of action of MYH and to identify potential drug targets or biomarkers for this protein.

Protein Name: Myosin IA

Functions: Involved in directing the movement of organelles along actin filaments

The "MYO1A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MYO1A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MYO1B | MYO1C | MYO1D | MYO1E | MYO1F | MYO1G | MYO1H | MYO3A | MYO3B | MYO3B-AS1 | MYO5A | MYO5B | MYO5C | MYO6 | MYO7A | MYO7B | MYO9A | MYO9B | MYOC | MYOCD | MYOD1 | MYOF | MYOG | MYOM1 | MYOM2 | MYOM3 | MYORG | Myosin | Myosin class II | Myosin light-chain phosphatase | MYOSLID | MYOSLID-AS1 | MYOT | MYOZ1 | MYOZ2 | MYOZ3 | MYPN | MYPOP | MYRF | MYRF-AS1 | MYRFL | MYRIP | MYSM1 | MYT1 | MYT1L | MYT1L-AS1 | MYZAP | MZB1 | MZF1 | MZF1-AS1 | MZT1 | MZT2A | MZT2B | N-acetylglucosamine-1-phosphotransferase | N-CoR deacetylase complex | N-Terminal Acetyltransferase A (NatA) Complex | N-Terminal Acetyltransferase C (NatC) Complex | N-Type Calcium Channel | N4BP1 | N4BP2 | N4BP2L1 | N4BP2L2 | N4BP2L2-IT2 | N4BP3 | N6AMT1 | NAA10 | NAA11 | NAA15 | NAA16 | NAA20 | NAA25 | NAA30 | NAA35 | NAA38 | NAA40 | NAA50 | NAA60 | NAA80 | NAAA | NAALAD2 | NAALADL1 | NAALADL2 | NAALADL2-AS3 | NAB1 | NAB2 | NABP1 | NABP2 | NACA | NACA2 | NACA3P | NACA4P | NACAD | NACC1 | NACC2 | NAD(P)H dehydrogenase, quinone | NAD-Dependent Protein Deacetylase | NADH dehydrogenase (Complex I) | NADK | NADK2 | NADPH Oxidase